×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Fabino Enterprises Ltd | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd | 2.21 | -1.32 | NA | -5.38 | 0 | |
| Sai Life Sciences Limited | 5648.44 | 1003.75 | 5564.64 | 4.71 | 17,962 | 73.6 |
| Neuland Laboratories Limited | 4477.62 | 405.72 | 4397.09 | 31.62 | 17918 | 136.0 |
| Alembic Pharmaceuticals Limited | 18918.1 | 1319.5 | 18763.1 | 6.76 | 17885 | 30.2 |
Sai Life Sciences Limited is listed on NSE.
| Metrics | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|
| Sales | 428.6 | 567.0 | 483.0 | 526.7 |
| Expenses | 317.4 | 413.0 | 370.0 | 386.8 |
| Operating Profit | 111.2 | 154.0 | 113.0 | 139.8 |
| OPM % | 25.94% | 27.15% | 23.39% | 26.55% |
| Other Income | 9.4 | 9.8 | 10.0 | 14.9 |
| Interest | 21.7 | 9.2 | 10.7 | 7.7 |
| Depreciation | 31.1 | 34.1 | 34.3 | 36.2 |
| Profit before tax | 67.9 | 120.5 | 78.0 | 110.9 |
| Tax % | -24.8% | -25.3% | 25.1% | 25.2% |
| Net Profit | 51.1 | 89.9 | 58.4 | 82.9 |
| EPS in Rs | 2.69 | 0 | 2.73 | 3.89 |
| Metrics | Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|
| Sales | 439.8 | 579.5 | 537.5 | 556.5 |
| Expenses | 320.0 | 421.9 | 391.6 | 368.6 |
| Operating Profit | 119.8 | 157.6 | 145.8 | 187.9 |
| OPM % | 27.23% | 27.19% | 27.13% | 33.76% |
| Other Income | 9.1 | 9.6 | 15.3 | 0.1 |
| Interest | 23.1 | 10.9 | 9.4 | 9.7 |
| Depreciation | 34.1 | 37.5 | 39.7 | 44.1 |
| Profit before tax | 71.6 | 118.8 | 112.1 | 142.5 |
| Tax % | 24.8% | -25.7% | -25.2% | 25.2% |
| Net Profit | 53.9 | 88.3 | 83.8 | 100.4 |
| EPS in Rs | 2.84 | 0 | 0 | 4.71 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 18% |
| 3 Years: | 25% |
| TTM: | 16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 17% |
| 3 Years: | 241% |
| TTM: | 82% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 25% |
| TTM: | 16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 229% |
| TTM: | 105% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|